BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27611921)

  • 21. Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV.
    Poppova L; Janovska P; Plevova K; Radova L; Plesingerova H; Borsky M; Kotaskova J; Kantorova B; Hlozkova M; Figulova J; Brychtova Y; Machalova M; Urik M; Doubek M; Kozubik A; Pospisilova S; Pavlova S; Bryja V
    Br J Haematol; 2016 Dec; 175(5):851-859. PubMed ID: 27651098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.
    Sharma S; Galanina N; Guo A; Lee J; Kadri S; Van Slambrouck C; Long B; Wang W; Ming M; Furtado LV; Segal JP; Stock W; Venkataraman G; Tang WJ; Lu P; Wang YL
    Oncotarget; 2016 Oct; 7(42):68833-68841. PubMed ID: 27626698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.
    Miller CR; Ruppert AS; Fobare S; Chen TL; Liu C; Lehman A; Blachly JS; Zhang X; Lucas DM; Grever MR; Tallman MS; Flinn IW; Rassenti LZ; Kipps TJ; Sampath D; Coombes KR; Hertlein EK
    Oncotarget; 2017 Apr; 8(16):25942-25954. PubMed ID: 28412730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting BTK through microRNA in chronic lymphocytic leukemia.
    Bottoni A; Rizzotto L; Lai TH; Liu C; Smith LL; Mantel R; Reiff S; El-Gamal D; Larkin K; Johnson AJ; Lapalombella R; Lehman A; Plunkett W; Byrd JC; Blachly JS; Woyach JA; Sampath D
    Blood; 2016 Dec; 128(26):3101-3112. PubMed ID: 27756747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
    Mozessohn L; Earle C; Spaner D; Cheng SY; Kumar M; Buckstein R
    J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia.
    Wang J; Morrissette J; Lieberman DB; Timlin C; Schuster SJ; Mato AR
    Br J Haematol; 2018 Jan; 180(2):299-301. PubMed ID: 27714764
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment.
    Zhang X; Wang H; Zhang Y; Wang X
    Clin Exp Med; 2024 Mar; 24(1):54. PubMed ID: 38492089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic Leukemia.
    Tomic Vujovic K; Ugrin M; Tosic N; Vukovic V; Marjanovic I; Kostic T; Stankovic S; Otasevic V; Sarac S; Antic D; Pavlovic S; Karan-Djurasevic T
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia.
    Xu Z; Pan B; Li Y; Xia Y; Liang J; Kong Y; Zhang X; Tang J; Wang L; Li J; Xu W; Wu J
    Int J Gen Med; 2023; 16():1541-1553. PubMed ID: 37131869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia.
    Gasic V; Karan-Djurasevic T; Pavlovic D; Zukic B; Pavlovic S; Tosic N
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362925
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Conteduca G; Cangelosi D; Coco S; Malacarne M; Baldo C; Arado A; Pinto R; Testa B; Coviello DA
    Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance.
    Drandi D; Decruyenaere P; Ferrante M; Offner F; Vandesompele J; Ferrero S
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SP1-Regulated Non-Coding RNA SNHG22 Promotes Ovarian Cancer Growth and Glycolysis.
    Guan N; Zheng H; Wu X; Xie L; Tong X
    Cancer Manag Res; 2021; 13():7299-7309. PubMed ID: 34584456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia.
    Morabito F; Tripepi G; Moia R; Recchia AG; Boggione P; Mauro FR; Bossio S; D'Arrigo G; Martino EA; Vigna E; Storino F; Fronza G; Di Raimondo F; Rossi D; Condoluci A; Colombo M; Fais F; Fabris S; Foa R; Cutrona G; Gentile M; Montserrat E; Gaidano G; Ferrarini M; Neri A
    Front Oncol; 2021; 11():684621. PubMed ID: 34408978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies.
    Drillis G; Goulielmaki M; Spandidos DA; Aggelaki S; Zoumpourlis V
    Oncol Lett; 2021 May; 21(5):393. PubMed ID: 33777216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe.
    Lingua MF; Carrà G; Maffeo B; Morotti A
    Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33669945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNAs in adaptive immunity: role in physiological and pathological conditions.
    Zeni PF; Mraz M
    RNA Biol; 2021 May; 18(5):619-632. PubMed ID: 33094664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia.
    Fabris L; Juracek J; Calin G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCALM (AC099524.1) Is a Human B Lymphocyte-Specific Long Noncoding RNA That Modulates B Cell Receptor-Mediated Calcium Signaling.
    Pyfrom SC; Quinn CC; Dorando HK; Luo H; Payton JE
    J Immunol; 2020 Aug; 205(3):595-607. PubMed ID: 32571842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.